Wenjuan Zhang

发表

Study of triaryl-based sulfamic acid derivatives as HPTPβ inhibitors.

Song Li, Fei Xie, Zhao Wei, 2020, Bioorganic & medicinal chemistry.

Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo.

Pengyun Li, Song Li, Changkai Jia, 2022, European journal of medicinal chemistry.

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism

Pengyun Li, Maoxiang Zhu, Yu Xia, 2022, Cell Death & Disease.

Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations

Jun-hai Xiao, Ke Liu, Pengyun Li, 2023, Acta pharmaceutica Sinica. B.

Discovery of highly potent and selective EGFRT790M/L858R TKIs against NSCLC based on molecular dynamic simulation.

Pengyun Li, Song Li, Xu Cai, 2021, European journal of medicinal chemistry.

Synthesis and biological evaluation of (3'-amino-[1,1'-biphenyl]-4-yl) sulfamic acid derivatives as novel HPTPβ inhibitors.

Song Li, Zhao Wei, Wenjuan Zhang, 2018, Bioorganic chemistry (Print).

Discovery and pharmacological characterization of a novel benzimidazole TRPV4 antagonist with cyanocyclobutyl moiety.

Mengyuan Wang, Zhibing Zheng, Hui-Min Song, 2023, European journal of medicinal chemistry.

3D-QSAR study of the phenylsulfamic acid derivatives as HPTPβ inhibitors

Song Li, Zhao Wei, Wenjuan Zhang, 2019, Journal of Molecular Structure.

Molecular modeling of three-dimensional structure of hTRPV4 protein and experimental verification of its antagonist binding sites

Zhibing Zheng, Lulu Zhou, Xu Cai, 2020 .

Combined scaffold hopping, molecular screening with dynamic simulation to screen potent CRBN ligands

Zhibing Zheng, Pengyun Li, Shi-Duo Sun, 2021, Journal of cellular biochemistry.